AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,000 | +44.4% | 40,606 | +64.8% | 0.00% | – |
Q2 2022 | $9,000 | -81.2% | 24,634 | +30.0% | 0.00% | – |
Q3 2020 | $48,000 | -61.9% | 18,947 | +49.8% | 0.00% | -100.0% |
Q2 2018 | $126,000 | -60.0% | 12,645 | -61.8% | 0.00% | 0.0% |
Q1 2018 | $315,000 | +76.0% | 33,099 | +174.7% | 0.00% | 0.0% |
Q4 2017 | $179,000 | -97.9% | 12,049 | -98.5% | 0.00% | -98.1% |
Q2 2015 | $8,524,000 | +453.1% | 828,357 | +497.3% | 0.05% | +333.3% |
Q1 2015 | $1,541,000 | -42.2% | 138,676 | -39.4% | 0.01% | -50.0% |
Q4 2014 | $2,665,000 | – | 228,934 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |